{"id":34521,"date":"2024-11-26T16:42:59","date_gmt":"2024-11-26T16:42:59","guid":{"rendered":"https:\/\/bnssghealthiertogether.org.uk\/?page_id=34521"},"modified":"2025-01-16T22:19:11","modified_gmt":"2025-01-16T22:19:11","slug":"pragmatic-evaluation-of-effectiveness-and-acceptability-of-the-bristol-medication-review-toolkit-brismed","status":"publish","type":"page","link":"https:\/\/bnssghealthiertogether.org.uk\/tr\/integrated-care-board\/research-and-evidence\/our-research-portfolio\/nihr-funded-projects\/pragmatic-evaluation-of-effectiveness-and-acceptability-of-the-bristol-medication-review-toolkit-brismed\/","title":{"rendered":"Bristol \u0130la\u00e7 De\u011ferlendirme Ara\u00e7 Seti'nin (BRISMED) Etkinli\u011finin ve Kabul Edilebilirli\u011finin Pragmatik De\u011ferlendirmesi"},"content":{"rendered":"
Mod\u00fcl-1 ba\u015fl\u0131kl\u0131 b\u00f6l\u00fcm<\/span><\/a>
\r\n
\r\n

Bristol \u0130la\u00e7 De\u011ferlendirme Ara\u00e7 Seti'nin (BRISMED) Etkinli\u011finin ve Kabul Edilebilirli\u011finin Pragmatik De\u011ferlendirmesi<\/h1>\n

Finansman:<\/strong><\/h2>\n

Bu proje, NIHR Sa\u011fl\u0131k ve Sosyal Bak\u0131m Sunumu Ara\u015ft\u0131rma (HSDR) Program\u0131, NIHR154205 taraf\u0131ndan finanse edilmektedir.<\/p>\n

Sorun nedir?<\/h2>\n

\u0130la\u00e7 de\u011ferlendirme toplant\u0131s\u0131nda hasta, kulland\u0131\u011f\u0131 ila\u00e7lar\u0131 g\u00f6r\u00fc\u015fmek \u00fczere bir pratisyen hekim veya eczac\u0131yla bir araya gelir. \u0130la\u00e7 de\u011ferlendirmeleri, hastan\u0131n ald\u0131\u011f\u0131 ila\u00e7lar\u0131n rahats\u0131zl\u0131\u011f\u0131 i\u00e7in do\u011fru ila\u00e7lar olup olmad\u0131\u011f\u0131n\u0131 kontrol etmek a\u00e7\u0131s\u0131ndan \u00f6nemlidir.<\/p>\n

\u0130ncelemeler ayr\u0131ca ila\u00e7lar\u0131n g\u00fcvenli ve etkili bir \u015fekilde kullan\u0131l\u0131p kullan\u0131lmad\u0131\u011f\u0131n\u0131 da kontrol eder.<\/p>\n

\u0130la\u00e7 de\u011ferlendirmeleri, uzun s\u00fcreli ila\u00e7 kullanan ki\u015filer i\u00e7in normal sa\u011fl\u0131k bak\u0131m\u0131n\u0131n bir par\u00e7as\u0131d\u0131r. Ancak ara\u015ft\u0131rmalar, ila\u00e7 de\u011ferlendirmelerinin her zaman bak\u0131m\u0131 iyile\u015ftirmedi\u011fini g\u00f6stermektedir.<\/p>\n

Ayr\u0131ca, hastalar ila\u00e7lar\u0131yla ilgili kararlara her zaman dahil edilmiyor. Ulusal Sa\u011fl\u0131k ve Bak\u0131m M\u00fckemmelli\u011fi Enstit\u00fcs\u00fc (NICE), NHS'ye tavsiye ve rehberlik sa\u011fl\u0131yor. NICE, daha iyi ila\u00e7 de\u011ferlendirmelerine ihtiya\u00e7 duyuldu\u011funu belirtmi\u015f ve bir\u00e7ok doktor ve eczac\u0131 da bu g\u00f6r\u00fc\u015fe kat\u0131l\u0131yor.<\/p>\n

Ara\u015ft\u0131rman\u0131n amac\u0131 nedir?<\/h2>\n

\u0130la\u00e7 de\u011ferlendirmelerini iyile\u015ftirmek amac\u0131yla, Bristol \u00dcniversitesi'ndeki ara\u015ft\u0131rmac\u0131lar "Bristol \u0130la\u00e7 De\u011ferlendirme Ara\u00e7 Seti"ni geli\u015ftirdiler. Doktorlar, eczac\u0131lar, hastalar ve ara\u015ft\u0131rmac\u0131lar bu ara\u00e7 setinin geli\u015ftirilmesinde birlikte \u00e7al\u0131\u015ft\u0131lar.<\/p>\n

Bu ara\u00e7 seti, doktorlara ve eczac\u0131lara ila\u00e7 de\u011ferlendirmesinin nas\u0131l yap\u0131laca\u011f\u0131na dair tavsiyeler sunar. Ayr\u0131ca hastalara da de\u011ferlendirmeden en iyi \u015fekilde nas\u0131l yararlanacaklar\u0131 konusunda tavsiyelerde bulunur.<\/p>\n

\u015eimdi, Bristol \u0130la\u00e7 De\u011ferlendirme ara\u00e7 setinin aile hekimli\u011fi uygulamalar\u0131na verilmesinin ila\u00e7 de\u011ferlendirmelerini iyile\u015ftirip iyile\u015ftirmedi\u011fini anlamak istiyoruz. Ayr\u0131ca hastalar\u0131n, doktorlar\u0131n ve eczac\u0131lar\u0131n ara\u00e7 setini kullanmay\u0131 kolay bulup bulmad\u0131\u011f\u0131n\u0131 da anlamak istiyoruz.<\/p>\n

Bu nas\u0131l ba\u015far\u0131lacak?<\/h2>\n

Proje \u00fc\u00e7 b\u00f6l\u00fcmden olu\u015fmaktad\u0131r:<\/p>\n

1. Bristol \u0130la\u00e7 De\u011ferlendirme ara\u00e7 setini Birle\u015fik Krall\u0131k genelindeki yakla\u015f\u0131k 500 pratisyen hekim muayenehanesine da\u011f\u0131taca\u011f\u0131z ve nas\u0131l kullan\u0131laca\u011f\u0131 konusunda tavsiyelerde bulunaca\u011f\u0131z. Ara\u00e7 setinin m\u00fcmk\u00fcn oldu\u011funca faydal\u0131 olmas\u0131n\u0131 ve muayenehanelerin onu do\u011fru \u015fekilde nas\u0131l kullanaca\u011f\u0131n\u0131 bilmesini sa\u011flamak i\u00e7in hastalar, pratisyen hekimler ve eczac\u0131larla g\u00f6r\u00fc\u015fece\u011fiz.<\/p>\n

2. Bir y\u0131l boyunca, Bristol ara\u00e7 setini kullanan 500 pratisyen hekim muayenehanesindeki ila\u00e7 kullan\u0131m\u0131n\u0131, bu seti kullanmayan 500 pratisyen hekim muayenehanesindeki ila\u00e7 kullan\u0131m\u0131yla kar\u015f\u0131la\u015ft\u0131raca\u011f\u0131z. Doktorlar ve eczac\u0131lar taraf\u0131ndan pratisyen hekim muayenehanelerinin bilgisayar sistemlerinde kaydedilen bilgileri toplayaca\u011f\u0131z. \u0130la\u00e7lar\u0131n g\u00fcvenli bir \u015fekilde kullan\u0131l\u0131p kullan\u0131lmad\u0131\u011f\u0131n\u0131 ve hastalara verilen ila\u00e7 say\u0131s\u0131 gibi di\u011fer hususlar\u0131 \u00f6\u011frenmek istiyoruz. Ayr\u0131ca sa\u011fl\u0131k hizmetlerinin kullan\u0131m\u0131ndaki di\u011fer de\u011fi\u015fiklikleri de (\u00f6rne\u011fin, hastaneye yat\u0131\u015flar) inceleyece\u011fiz.<\/p>\n

3. \u0130la\u00e7 de\u011ferlendirmeleri hakk\u0131ndaki g\u00f6r\u00fc\u015f ve deneyimlerini \u00f6\u011frenmek i\u00e7in hastalar, doktorlar ve eczac\u0131larla g\u00f6r\u00fc\u015fmeler yapaca\u011f\u0131z. Baz\u0131 doktor ve eczac\u0131lara Bristol ara\u00e7 setini kullanma deneyimleri hakk\u0131nda sorular soraca\u011f\u0131z. Baz\u0131 hastalara ila\u00e7 de\u011ferlendirmeleri hakk\u0131ndaki deneyimlerini \u00f6\u011frenmek i\u00e7in bir anket g\u00f6nderece\u011fiz. Ayr\u0131ca, ila\u00e7 de\u011ferlendirmelerinin nas\u0131l yap\u0131ld\u0131\u011f\u0131n\u0131, ara\u00e7 setiyle ve ara\u00e7 seti olmadan anlamak i\u00e7in baz\u0131 ila\u00e7 de\u011ferlendirmelerini ses kayd\u0131na alaca\u011f\u0131z, pratisyen hekim muayenehanelerine anket uygulayaca\u011f\u0131z ve bilgisayar sistemlerinden bilgi toplayaca\u011f\u0131z.<\/p>\n

Bu sonu\u00e7lar, gelecekte ila\u00e7 de\u011ferlendirmelerini en iyi \u015fekilde nas\u0131l yapaca\u011f\u0131m\u0131z\u0131 bulmam\u0131za yard\u0131mc\u0131 olacakt\u0131r. Bu, ila\u00e7lar\u0131n g\u00fcvenli ve etkili bir \u015fekilde kullan\u0131lmas\u0131n\u0131 sa\u011flayacakt\u0131r. Ayr\u0131ca hastalar\u0131n ila\u00e7lar\u0131yla ilgili g\u00f6r\u00fc\u015fmelere tam olarak dahil olmalar\u0131n\u0131 da sa\u011flayacakt\u0131r.<\/p>\n

E\u011fer bu ara\u00e7 seti faydal\u0131 ve kullan\u0131m\u0131 kolay olursa, t\u00fcm aile hekimli\u011fi uygulamalar\u0131na sunulmas\u0131 da kolay olacakt\u0131r.<\/p>\n

Bulgular\u0131m\u0131z\u0131 doktorlar, eczac\u0131lar, NHS y\u00f6neticileri ve politika yap\u0131c\u0131lar (hangi sa\u011fl\u0131k hizmetlerinin sa\u011flanaca\u011f\u0131na karar verenler) ve di\u011fer ara\u015ft\u0131rmac\u0131larla payla\u015faca\u011f\u0131z.<\/p>\n

Hastalar ve halktan ki\u015filer, ara\u015ft\u0131rma tasar\u0131m\u0131na ve test etti\u011fimiz ara\u00e7 setine katk\u0131da bulundular. Ayr\u0131ca ara\u015ft\u0131rman\u0131n y\u00fcr\u00fct\u00fclmesine ve bulgular\u0131m\u0131z\u0131n herkesin anlayabilece\u011fi \u015fekilde payla\u015f\u0131lmas\u0131na da yard\u0131mc\u0131 olacaklar.<\/p>\n

Ara\u015ft\u0131rmay\u0131 kim y\u00fcr\u00fct\u00fcyor?<\/h2>\n

Dr. Deborah McCahon<\/a>, Bristol \u00dcniversitesi Ara\u015ft\u0131rma G\u00f6revlisi ve Profes\u00f6r Rupert Payne<\/a>, Exeter \u00dcniversitesi Birinci Basamak Sa\u011fl\u0131k Hizmetleri ve Klinik Farmakoloji Profes\u00f6r\u00fc.<\/p>\n

Daha fazla bilgi:<\/h2>\n

Daha fazla bilgi almak veya bu projeye dahil olmak i\u00e7in l\u00fctfen e-posta g\u00f6nderin. bnssg.research@nhs.net<\/a><\/p>\n <\/div>\r\n <\/section><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"

Section titled module-1 Pragmatic Evaluation of Effectiveness and Acceptability of the Bristol Medication Review Toolkit (BRISMED) Funding: This project is funded by the NIHR Health and Social Care Delivery Research (HSDR) Programme, NIHR154205. What is the problem? At a medication review a patient meets a GP or pharmacist to discuss the medicines they are using. […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":32881,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"tags":[],"class_list":["post-34521","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/tr\/wp-json\/wp\/v2\/pages\/34521","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/tr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/tr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/tr\/wp-json\/wp\/v2\/comments?post=34521"}],"version-history":[{"count":3,"href":"https:\/\/bnssghealthiertogether.org.uk\/tr\/wp-json\/wp\/v2\/pages\/34521\/revisions"}],"predecessor-version":[{"id":36169,"href":"https:\/\/bnssghealthiertogether.org.uk\/tr\/wp-json\/wp\/v2\/pages\/34521\/revisions\/36169"}],"up":[{"embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/tr\/wp-json\/wp\/v2\/pages\/32881"}],"wp:attachment":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/tr\/wp-json\/wp\/v2\/media?parent=34521"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/tr\/wp-json\/wp\/v2\/tags?post=34521"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}